Oral transmucosal drug delivery - Current status and future prospects

被引：111

作者：

Sattar, Mohammed ^{[1
,2
]}

Sayed, Ossama M. ^{[1
,3
]}

Lane, Majella E. ^{[1
]}

机构：

[1] UCL Sch Pharm, Dept Pharmaceut, London WC1N 1AX, England

[2] Univ Basrah, Dept Pharmaceut, Coll Pharm, Basrah, Iraq

[3] Beni Suef Univ, Dept Pharmaceut, Fac Pharm, Bani Suwayf, Egypt

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2014年 / 471卷 / 1-2期

关键词：

Oral transmucosal drug delivery; Buccal; Sublingual; Models; Formulations; PORCINE BUCCAL MUCOSA; IN-VITRO MODEL; TR146; CELL-CULTURE; TRANSBUCCAL DELIVERY; EX-VIVO; INTRAORAL DEVICE; BIOMEMBRANE PERMEATION; PARTITION COEFFICIENTS; SODIUM GLYCOCHOLATE; ALTERNATIVE ROUTE;

D O I：

10.1016/j.ijpharm.2014.05.043

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oral transmucosal drug delivery (OTDD) dosage forms have been available since the 1980s. In contrast to the number of actives currently delivered locally to the oral cavity, the number delivered as buccal or sublingual formulations remains relatively low. This is surprising in view of the advantages associated with OTDD, compared with conventional oral drug delivery. This review examines a number of aspects related to OTDD including the anatomy of the oral cavity, models currently used to study OTDD, as well as commercially available formulations and emerging technologies. The limitations of current methodologies to study OTDD are considered as well as recent publications and new approaches which have advanced our understanding of this route of drug delivery. (C) 2014 Elsevier B.V. All rights reserved.

引用

页码：498 / 506

页数：9

共 113 条

[1] Construction and in vitro characterization of an optimized porosity-enabled amalgamated matrix for sustained transbuccal drug delivery [J].

Adeleke, Oluwatoyin A. ;

Pillay, Viness ;

du Toit, Lisa C. ;

Choonara, Yahya E. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 391 (1-2) :79-89

[2] In vivo human buccal permeability of nicotine [J].

Adrian, CL ;

Olin, HBD ;

Dalhoff, K ;

Jacobsen, J .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 311 (1-2) :196-202

[3] A comparative ex vivo drug permeation study of beta-blockers through porcine buccal mucosa [J].

Amores, Sonia ;

Lauroba, Jacinto ;

Calpena, Ana ;

Colom, Helena ;

Gimeno, Alvaro ;

Domenech, Jose .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) :50-54

[4] Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies [J].

Artusi, M ;

Santi, P ;

Colombo, P ;

Junginger, HE .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :203-213

[5] Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate [J].

Avachat, Amelia M. ;

Gujar, Kishore N. ;

Wagh, Kishor V. .

CARBOHYDRATE POLYMERS, 2013, 91 (02) :537-542

[6] MODEL FOR STEROID TRANSPORT ACROSS BIOLOGICAL-MEMBRANES [J].

BECKETT, AH ;

PICKUP, ME .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (04) :226-234

[7] KINETICS OF BUCCAL ABSORPTION OF SOME CARBOXYLIC ACIDS AND CORRELATION OF RATE CONSTANTS AND N-HEPTANE.AQUEOUS PHASE PARTITION COEFFICIENTS [J].

BECKETT, AH ;

MOFFAT, AC .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (01) :15-&

[8] BUCCAL ABSORPTION OF SOME BARBITURATES [J].

BECKETT, AH ;

MOFFAT, AC .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (01) :15-+

[9] INFLUENCE OF SUBSTITUTION IN PHENYLACETIC ACIDS ON THEIR PERFORMANCE IN BUCCAL ABSORPTION TEST [J].

BECKETT, AH ;

MOFFAT, AC .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, S 21 :S139-&

[10]

BECKETT AH, 1967, J PHARM PHARMACOL, VS 19, pS31

← 1 2 3 4 5 6 7 8 9 10 →